APA (7th ed.) Citation

Ong, K. L., Rye, K., O'Connell, R., Jenkins, A. J., Brown, C., Xu, A., . . . Keech, A. C. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. The journal of clinical endocrinology and metabolism, 97(12), 4701-4708. https://doi.org/10.1210/jc.2012-2267

Chicago Style (17th ed.) Citation

Ong, Kwok Leung, Kerry-Anne Rye, Rachel O'Connell, Alicia J. Jenkins, Chris Brown, Aimin Xu, David R. Sullivan, Philip J. Barter, and Anthony C. Keech. "Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes." The Journal of Clinical Endocrinology and Metabolism 97, no. 12 (2012): 4701-4708. https://doi.org/10.1210/jc.2012-2267.

MLA (9th ed.) Citation

Ong, Kwok Leung, et al. "Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes." The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, 2012, pp. 4701-4708, https://doi.org/10.1210/jc.2012-2267.